


This Fund aims to achieve long-term capital growth.
| Name | % Net Assets |
|---|---|
| Microsoft | 3.1% |
| Procter & Gamble | 3.0% |
| Exxon Mobil | 2.8% |
| Covidien | 2.6% |
| General Electric | 2.5% |
| Pfizer | 2.4% |
| Comcast | 2.4% |
| Chevron | 2.3% |
| General Dynamics | 2.3% |
| Apple | 2.2% |
| Key | % Net Assets |
|---|---|
| 3.1% | |
| 3.0% | |
| 2.8% | |
| 2.6% | |
| 88.5% |
| Date | 20-Sep-2019 |
|---|---|
| NAV | 231.97p |
| Currency | GBP |
| Change | -1.24p |
| % | -0.53% |
| YTD change | 231.97p |
| YTD % | n/a |
| Fund Inception | 14/10/2002 |
|---|---|
| Fund Manager | Tom Digenan |
| TER | 1.68 (31-Jan-2014) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £500 |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | 4.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | -0.04 |
You are here: research